A detailed history of Gen Trust, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gen Trust, LLC holds 852 shares of LLY stock, worth $635,762. This represents 0.04% of its overall portfolio holdings.

Number of Shares
852
Previous 675 26.22%
Holding current value
$635,762
Previous $611,000 23.4%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $136,668 - $169,923
177 Added 26.22%
852 $754,000
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $171,738 - $229,761
290 Added 75.32%
675 $525,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $167,359 - $230,730
385 New
385 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gen Trust, LLC Portfolio

Follow Gen Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gen Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gen Trust, LLC with notifications on news.